Insider Transactions in Q4 2020 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2020
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
280,000
-22.79%
|
$22,680,000
$81.41 P/Share
|
|
Oct 30
2020
|
Steven Mizell EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,273
-29.81%
|
$170,475
$75.89 P/Share
|
|
Oct 30
2020
|
Steven Mizell EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,574
+37.5%
|
$343,050
$75.89 P/Share
|
|
Oct 30
2020
|
Michael Nally EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
995
-7.42%
|
$74,625
$75.89 P/Share
|
|
Oct 30
2020
|
Michael Nally EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,287
+14.58%
|
$171,525
$75.89 P/Share
|
|
Oct 30
2020
|
Frank Clyburn EVP & Pres ? Human Health |
SELL
Payment of exercise price or tax liability
|
Direct |
1,137
-1.36%
|
$85,275
$75.89 P/Share
|
|
Oct 30
2020
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,287
+2.66%
|
$171,525
$75.89 P/Share
|
|
Oct 05
2020
|
Robert M Davis Chairman, CEO & President |
SELL
Open market or private sale
|
Direct |
251,273
-59.5%
|
$20,353,113
$81.03 P/Share
|
|
Oct 05
2020
|
Robert M Davis Chairman, CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
251,273
+37.3%
|
-
|